Bone marrow engraftment and associated dermatologic sequelae in a three‐yr‐old after liver transplantation
暂无分享,去创建一个
Heung Bae Kim | B. Degar | Jennifer T. Huang | R. Fawaz | Jennifer K. Tan | A. Saavedra | B. Schmidt | J. Sheu | Barbara A. Degar | Arturo P. Saavedra | C. Duncan
[1] J. Neuberger,et al. Autoimmune liver disease, autoimmunity and liver transplantation. , 2014, Journal of hepatology.
[2] B. van Hoek,et al. Acute cellular rejection is associated with matrix metalloproteinase-2 genotype chimerism after orthotopic liver transplantation. , 2013, Transplantation proceedings.
[3] R. Fisher,et al. Graft-versus-host disease after solid organ transplantation: a single center experience and review of literature. , 2012, Annals of transplantation.
[4] S. Akbulut,et al. Graft-versus-host disease after liver transplantation: a comprehensive literature review. , 2012, World journal of gastroenterology.
[5] S. Fan,et al. Hematopoietic chimerism in liver transplantation patients and hematopoietic stem/progenitor cells in adult human liver , 2012, Hepatology.
[6] T. Liang,et al. Mesenchymal stem cells administered after liver transplantation prevent acute graft‐versus‐host disease in rats , 2012, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[7] P. Cochat,et al. Et al , 2008, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.
[8] M. Clatworthy,et al. Vitiligo following a combined liver-kidney transplant. , 2008, Nephrology, Dialysis and Transplantation.
[9] B. N. Akay,et al. Vitiligo after Hematopoietic Cell Transplantation: Six Cases and Review of the Literature , 2008, Dermatology.
[10] S. Alexander,et al. Chimerism and tolerance in a recipient of a deceased-donor liver transplant. , 2008, The New England journal of medicine.
[11] T. Starzl. Immunosuppressive therapy and tolerance of organ allografts. , 2008, The New England journal of medicine.
[12] M. Manns,et al. Clinical relevance of autoantibodies after pediatric liver transplantation , 2007, Clinical transplantation.
[13] G. Klintmalm,et al. Acute Graft versus Host Disease After Liver Transplantation: Patterns of Lymphocyte Chimerism , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[14] T. Starzl,et al. Use of Alemtuzumab and Tacrolimus Monotherapy for Cadaveric Liver Transplantation: With Particular Reference to Hepatitis C Virus , 2004, Transplantation.
[15] G. Alexander,et al. Monitoring systemic donor lymphocyte macrochimerism to aid the diagnosis of graftversus-host disease after liver transplantation , 2004, Transplantation.
[16] S. Fan,et al. High frequency of chimerism in transplanted livers , 2003, Hepatology.
[17] M. Maris,et al. Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation. , 2003, Blood.
[18] J. Ringers,et al. Extensive chimerism in liver transplants: Vascular endothelium, bile duct epithelium, and hepatocytes , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[19] Y. Kwong,et al. Graft‐versus‐host disease after liver transplantation: documentation by fluorescent in situ hybridisation and human leucocyte antigen typing , 2000, Clinical transplantation.
[20] J. Snowden,et al. Development of psoriasis after syngeneic bone marrow transplant from psoriatic donor: further evidence for adoptive autoimmunity , 1997, The British journal of dermatology.
[21] H. Schlitt,et al. PASSENGER LYMPHOCYTES IN HUMAN LIVER ALLOGRAFTS AND THEIR POTENTIAL ROLE AFTER TRANSPLANTATION , 1993, Transplantation.
[22] R. Collins,et al. Brief report: donor-derived long-term multilineage hematopoiesis in a liver-transplant recipient. , 1993, The New England journal of medicine.
[23] T. Starzl,et al. Chimerism after liver transplantation for type IV glycogen storage disease and type 1 Gaucher's disease. , 1993, The New England journal of medicine.
[24] P. Lavin,et al. Histiocytosis-X: Demonstration of Abnormal Immunity, T-Cell Histamine H2-Receptor Deficiency, and Successful Treatment with Thymic Extract , 1981 .